Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Indolent Non-Hodgkin Lymphoma × Lymphoid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma 288 Precursor Cell Lymphoblastic Leukemia-Lymphoma 248 Lymphoma, Large B-Cell, Diffuse 196 Lymphoma, Non-Hodgkin 170 Lymphoma, Follicular 156 Leukemia, Lymphocytic, Chronic, B-Cell 121 Lymphoma, B-Cell 106 Hodgkin Disease 100 Leukemia 92 Recurrence 91 Lymphoma, Mantle-Cell 86 Burkitt Lymphoma 84 Lymphoma, T-Cell, Peripheral 53 Lymphoma, B-Cell, Marginal Zone 49 Multiple Myeloma 46 Lymphoma, Extranodal NK-T-Cell 45 Leukemia, Myeloid, Acute 40 Neoplasms 34 Leukemia, B-Cell 34 Lymphoma, T-Cell, Cutaneous 33 Lymphoma, T-Cell 33 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 32 Lymphoma, Large-Cell, Immunoblastic 30 Myelodysplastic Syndromes 26 Waldenstrom Macroglobulinemia 22 Neoplasms, Plasma Cell 21 Mycosis Fungoides 21 Lymphoma, Large-Cell, Anaplastic 21 Hematologic Neoplasms 20 Immunoblastic Lymphadenopathy 19

Interventions

obinutuzumab 1 ibrutinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02689869 2021-05-07

Alternative

Ludwig-Maximilians - University of Munich

Phase 2 Unknown

Indolent Non-Hodgkin Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡